Marc Dunoyer
Executive Director and Chief Financial Officer
Member of the Board and CFO since November 2013
AstraZeaneca
Greece
Biography
Marc Dunoyer Executive Director and Chief Financial Officer Member of the Board and CFO since November 2013 Skills and experience Marc’s career in pharmaceuticals, which has included periods with Roussel Uclaf, Hoechst Marion Roussel and GlaxoSmithKline (GSK), has given him extensive industry experience, including finance and accounting; corporate strategy and planning; research and development; sales and marketing; business reorganisation; and business development. Marc is a qualified accountant and joined AstraZeneca in 2013, serving as Executive Vice-President, GPPS from June to October 2013. Prior to that, he served as Global Head of Rare Diseases at GSK and (concurrently) Chairman, GSK Japan. He holds an MBA from HEC, Paris and a Bachelor of Law degree from Paris University.
Research Interest
Executive Director and Chief Financial Officer Executive Director and Chief Financial Officer AstraZeneca, a pharmaceutical company, announced that Marc Dunoyer will join in the newly created role of EVP, global portfolio and product strategy, effective the second quarter .
